The Global Dog Cancer Therapeutics Market was valued at USD 210 million and is projected to reach a market size of USD 295.49 million by the end of 2030. Over the forecast period of 2024-2030, the market is projected to grow at a CAGR of 5%.
Dog cancer therapeutics is a medical treatment that focuses on managing and treating cancer in dogs. Cancer in dogs can take various forms such as tumours, abnormal cell growth, malignant neoplasms, and others. Further, cancer in dogs is one of the leading causes of death in dogs, especially old-aged dogs. As per AVMA (American Veterinary Medical Association) 1 in 4 dogs suffer from neoplasia – (it is an uncontrolled and abnormal growth of cells or tissues in the dog’s body that is referred to as neoplasm or tumour.). Further, dogs are more prone to getting cancer compared to other animals such as cats. Therefore, cancer therapeutics for dogs have gained momentum that helps in controlling and preventing the disease, reducing cancer symptoms, and improving dogs’ quality of life. Furthermore, some of the common symptoms that pose a threat to the dog’s life include abnormal growth of cells, lumps growth, weight loss and appetite loss, lethargy, persistent lameness, and others. Hence, there is a rising need to mitigate these symptoms in dogs and save their lives. Some of the therapeutics include surgical procedures such as removing a tumour from the dog’s body, chemotherapy that uses anti-cancer drugs to destroy cancer cell growth in dogs, radiation therapy that uses high-energy beams for destroying cancer cells, and immunotherapy that utilizes immune-boosting drugs to boost dog’s immune system and reduce the exposure of cancer cells attacking the dog’s body.
Apart from this, developments in veterinary treatments and research and developments in dog cancer therapeutics have boosted the market for dog cancer therapeutics.
Global Dog Cancer Therapeutics Market Drivers:
Advancements in veterinary treatment drive the market for dog cancer therapeutics.
The veterinary treatment sector has witnessed immense growth in recent years owing to rapid advancements in medical science and technology, which includes imaging technologies, surgical procedures, cancer detection and prevention techniques, and others. Further imaging technologies have helped veterans to detect cancer growth in dogs and recommend measures to curb them. These include the use of ultrasound technology that uses sound waves to generate images of the internal organs of a dog, computed tomography is used to get detailed cross-sectional images of the dog’s body such as tumours, lymph nodes, and others, magnetic resonance imaging (MRI) is used in cases of complexity for analyzing brain tumours through images generated by magnetic and radio waves, and others that help veterinarians visualize tumours, assess the size of the tumour, analyze the cell growth in surrounding areas, and others. Moreover, developments in scanning technology such as generating 3D images of the body using CT scans have contributed towards the market growth of dog cancer therapeutics. In addition to that, the use of molecular diagnostics has increased in veterinary oncology to analyze the genetic and molecular markers in dogs which further helps veterinarians to understand the genetic mutations in specific types of cancer. These advancements have helped veterinarians make better treatment decisions and develop better treatment strategies for dog cancer.
The increasing incidence of cancer in dogs has boosted the market for dog cancer therapeutics.
There has been an increase in cancer in dogs that are contributing towards dog cancer therapeutics, as it helps to increase the lifespan of dogs and improve their immunity. Moreover, as per National Cancer Institute, each year, 6 million new cancer diagnoses are made in dogs and lymphoma is the most common cancer seen in dogs. Further, environmental factors are one of the prime reasons for cancer in dogs. Dogs' exposure to tobacco smoke, chemicals, pesticides, pollutants, and others has increased the risk of cancer in them such as nasal and lung cancer. Additionally, genetic mutation in dog breeds is a major contributor to cancer development in dogs. The most common breeds exposed to genetic cancer mutation include golden retrievers, Bernese mountain dogs, Scottish terriers, and boxers. Further, improvement in diagnostic capabilities helps to detect early-stage cancer development in dogs and reduces dog mortality due to cancer to a greater extent.
Global Dog Cancer Therapeutics Market Challenges:
The expensive cost of cancer treatment is the biggest challenge to this market. Expensive treatment costs such as specialized therapies, diagnostics, and supportive care can be a burden for pet owners. Further, complex cancer types require advanced treatments including radiation therapy, which increases the cost of treatment. Apart from this, the expensive cost of post-treatment drugs that helps in boosting the immunity of dogs and supportive care services by veterinarian centre can act as a deterrent to the market growth of dog cancer therapeutics.
Global Dog Cancer Therapeutics Market Opportunities:
The Global Dog Cancer Therapeutics Market is anticipated to deliver lucrative opportunities for businesses, which include acquisitions, partnerships, collaborations, product launches and agreements during the forecasted period. Furthermore, owing to the increase in cancer risks among dogs and advancements in veterinarian oncology are predicted to develop the market for Dog Cancer Therapeutics and enhance its future growth opportunities.
The pandemic had affected the dog cancer therapeutics market. Due to the global lockdown, there was limited access to veterinary services as hospitals and other healthcare centres were more focused on treating virus-infected human patients. Moreover, there was a delay in seeking veterinary services, which resulted in a delay in cancer therapy in dogs. Further, due to supply chain disruption, there was a shortage of medical equipment and components that were essential in the diagnosing of cancer in dogs. However, the emerging trend of telemedicine increased dog health consultations online, which helped to reduce future disease risks in dogs.
Global Dog Cancer Therapeutics Market Recent Developments:
DOG CANCER THERAPEUTICS MARKET REPORT COVERAGE:
|
REPORT METRIC |
DETAILS |
|
Market Size Available |
2022 - 2030 |
|
Base Year |
2022 |
|
Forecast Period |
2023 - 2030 |
|
CAGR |
5% |
|
Segments Covered |
By Product, Type, Consumption, Distribution Channel and Region |
|
Various Analyses Covered |
Global, Regional & Country Level Analysis, Segment-Level Analysis, DROC, PESTLE Analysis, Porter’s Five Forces Analysis, Competitive Landscape, Analyst Overview on Investment Opportunities |
|
Regional Scope |
North America, Europe, APAC, Latin America, Middle East & Africa |
|
Key Companies Profiled |
Aratana Therapeutics, Vetivax, Regeneus, Zoetis, Torigen Pharmaceuticals, Qbiotics, ELIAS Animal Health, NovaVive |
Global Dog Cancer Therapeutics Market Segmentation:
Based on market segmentation by cancer type, lymphoma is the most common cancer type in dogs. It is a cancer in the lymphatic system that is a part of the immune system. It affects various organs such as lymph nodes, spleen, liver, and bone marrow. Further, its symptoms include difficulty in breathing, vomiting, and diarrhoea. Further, the most common breed affected by this cancer is golden retrievers. Moreover, treatments like chemotherapy and multidrug therapy witness an increasing need to cure this type of cancer.
Mast cell tumour is the second most common type of cancer in dogs, especially common in boxers and bulldogs. It forms on the skin of the dog and affects the immune cells of dogs. Its symptoms include vomiting, diarrhoea, and loss of appetite. Further, chemotherapy and radiation therapy is the most common treatment that helps to reduce the tumour in the dog’s body.
Melanoma is a type of oral cancer that is most commonly found in dog breeds with dark tongues and gums. These breeds include Doberman pinschers, standard and miniature schnauzers, chow chows, and Scottish terriers. Melanoma is composed of dark pigment cells that are found anywhere on the body and can spread throughout the body by the oral cavity. Further, it is the most difficult cancer to cure and often requires advanced therapies such as radiation therapy and immune-based therapy.
Based on market segmentation by treatment type, chemotherapy occupies the highest share in the market. It is the most common treatment used for dog cancer that helps to kill cancer cells and reduce the risk of cancer. Further, its capability to target cancer cells and its spread to other parts of the body makes it a popular option for treating dog cancer. Further, it aids in reducing cancer cell growth by shrinking tumours, controlling their growth, and eliminating the symptoms of cancer. Furthermore, it is considered a primary treatment for certain cancer types such as lymphoma and helps in improving the quality of life of dogs.
Radiation therapy occupies a significant share of the market owing to destroying cancer cells both internally and externally. It utilizes high-energy beams to destroy cancer cells. Moreover, it is further classified into two types – External beam radiation therapy and Brachytherapy. External beam radiation therapy utilizes an external machine that directs the radiation beams towards the tumour areas and brachytherapy places the radiation source inside the tumour of the dog. Both these types of therapy help to minimize damage to the healthy tissues and improve the dog’s health. Further, it is often used in combination with other therapies such as chemotherapy to increase a dog’s lifespan and prevents the cells from growing further in the body.
Immunotherapy occupies a sizeable market share owing to its ability in stimulating the immune system and destroy cancer cells. This is done via various approaches such as immune checkpoint inhibitors, monoclonal antibodies, and cancer vaccines. Further, immunotherapy is not effective for all types of cancer and require careful assessment and recognition of specific cancer type in dogs, their stages, and overall health.
Due to rising pet ownership and an increase in demand for pet healthcare, the demand for dog cancer therapeutics has increased in the region. Nearly, every household in North America owns a pet, of which dog is the most common type of pet. Further, dog owners consider their dogs as family members and companions, giving rise to the demand for pet healthcare in the region. Further, people in this region regularly consult veterinarians for a monthly check-up of their dogs that prevents them from future health risks. Further, the easy availability of advanced medicines and veterinarian oncologists have bolstered the market for dog cancer therapeutics in the region
Asia-Pacific is the fastest growing region during the forecast period owing to rising awareness about pet healthcare among pet owners and an increase in the presence of non-profit organizations and animal welfare organizations that have contributed towards the growth of dog cancer therapeutics in the region. Further, frequent pet-health awareness campaigns and seminars have increased the demand for dog cancer therapies that helps in improving the quality of life of dogs in the long run.
Global Dog Cancer Therapeutics Market Key Players:
Global automotive lighting refers to all vehicle lighting systems, from headlamps that illuminate the road to taillights that communicate movements. They guarantee motorists and other road users alike safety, visibility, and style. While taillights frequently use LEDs for improved visibility, headlights are available in a variety of technologies, including LED and laser. Interior illumination, DRLs, and signal lights all have a role to play. This market, which was estimated to be worth $33.64 billion in 2022, is anticipated to rise to $67.39 billion by 2030 because of laws, luxury tastes, safety concerns, and technological developments like OLED taillights and adaptive headlights. Anticipate a future dominated by intelligent, connected, personalized, and sustainable lighting systems that enhance the safety, efficiency, and aesthetic appeal of automobiles.
Car lighting works its magic to provide safety, visibility, and style. Headlights cut through the night, taillights express intent, and interiors shine with comfort. The billion-dollar global business is expected to rise due to consumer demand for high-end experiences, safer roads, and cutting-edge technology. Imagine dynamic messages being painted by taillights, headlights that adjust to the road, and interiors that customize their atmosphere. Driven by technological advancements like linked systems and laser beams, this future is calling. Anticipate even more visually attractive, environmentally friendly, and intelligent lighting to illuminate the way ahead, making cars safer, more efficient, and unquestionably cooler.
In the market for automobile lighting, safety is the driving force behind demand from the public and laws. While automated high beams smoothly react to traffic, adaptive headlights modify their beams so as not to blind other people. With visually striking displays, dynamic taillights convey intentions for braking and turning. Beyond these developments, integrated pedestrian identification and lane departure alerts will soon make roads safer and brighter for everyone.
Luxurious automobile lighting creates a distinct visual identity that goes beyond simple illumination. Personalized interior lighting customizes the driving experience by setting the mood with a range of colours and intensities, while intricate designs and distinctive DRLs modify exteriors. As you approach your automobile at night, welcoming lights lead the way, resulting in an interior that is perfectly lit. Not only is this symphony of light aesthetically pleasing, but it also stands as a tribute to luxury. Upcoming developments like gesture-controlled lighting and holographic displays promise to further enhance the experience.
The worldwide automotive lighting market is undergoing a significant transition towards energy-efficient solutions, as environmental concerns gain prominence. LED technology is leading the way, providing a ray of hope for the environment and drivers alike. LED lights beam brighter and use a lot less energy than conventional halogen lamps. There are some tangible advantages to this. For drivers, this translates to increased fuel economy, which lowers petrol prices and lessens reliance on fossil fuels. Greater air quality and a reduction in the transport sector's contribution to climate change are the results of reduced overall emissions.
Although the global automotive lighting business is booming, there are still unknowns. Difficulties impede growth even as innovation propels it with eye catching features like laser beams and adaptable headlights. These technologies are luxury items due to their high cost and difficult integration, which puts producers' abilities to the test. The worldwide patchwork created by unclear legislation limits the potential of innovation. Durability issues persist, particularly when complex systems are subjected to challenging conditions. Ultimately, a lot of drivers still don't fully understand how these improvements can help them. Together, we can overcome these obstacles. The keys to reducing costs are improved production, more seamless integration, and unified regulations. Their full potential can be realized by educating customers about the safety, efficiency, and aesthetic value of these lighting wonders. By working together, we can pave the way for an even brighter and safer future for vehicle lighting.
It is made possible by advanced LED technology, which gives drivers the ability to customize their illumination for the highest level of comfort and flair. Consumers that care about the environment want greener products, and vehicle lighting complies. While solar- and self-powered lighting technologies offer a future powered by clean energy, energy-efficient LEDs lower pollution. The advent of connected lighting systems heralds a new age. Envision automobiles interacting with infrastructure and one another to minimize accidents and enhance traffic efficiency. Integrated headlights with pedestrian recognition provide unmatched safety, while dramatic taillights with eye-catching displays alert onlookers to your intentions. The possibilities are endless in the future. Gesture-controlled interior illumination, holographic displays projected onto the road, and even light fixtures with self-healing capabilities.
Due to laws requiring safety features like headlights, taillights, and brake lights, exterior lighting presently holds the most market share in the vehicle lighting industry. The dominance of this market is partly attributed to advancements in safety-focused technologies such as adaptive headlights and daytime running lights. The market value of external lighting is increased by the quick adoption of technology like LED bulbs and laser lights, which improve performance and aesthetics. Conversely, the interior lighting market is expected to increase at the fastest rate in the upcoming years. Innovations like ambient lighting and technology breakthroughs like LED and OLED displays, driven by consumer demand for comfort and personalisation, open new possibilities. The spread of sophisticated interior lighting systems is further driven by the growing emphasis on safety and the expansion of the luxury car market.
The worldwide vehicle lighting market is currently dominated by halogen because of its more affordable price, advanced technology, and useful illumination. With its dependable supply chain and affordable option for manufacturers and cost-conscious customers, halogen holds the biggest market share. The fastest-growing market right now is LEDs, which are predicted to shortly overtake halogen. The rapid expansion of LEDs is driven by their higher efficiency, longer lifespan, flexibility in design, and technological breakthroughs including enhanced brightness. Because LEDs use less energy and produce fewer emissions and better fuel economy, they are becoming more and more popular in the changing automotive lighting market.
Passenger automobiles rule the worldwide automotive lighting market. The sheer number of passenger cars produced which surpasses that of business vehicles and fuels the need for lighting systems is the primary cause of this popularity. The growing demand for personal automobiles in developing nations is a result of rising disposable income, which in turn drives the rise of the passenger car market. The importance that consumers place on safety and aesthetics elements helps to drive market expansion. But in the upcoming years, the market for electric and hybrid cars is expected to develop at the quickest rate. The exponential rise of the worldwide electric car market, which is still expanding and shows no signs of slowing down, is what is driving this surge. Specialised lighting solutions are required since electric and hybrid vehicles have different lighting requirements because of their specific functionality and design aesthetics.
Most lighting systems sold nowadays are sold by OEMs (Original Equipment Manufacturers), primarily because manufacturers pre-install lighting systems in new cars. But in the next years, the aftermarket is expected to develop at the quickest rate. This spike in demand for replacement parts, especially lighting systems, can be linked to several variables, one of them being the average age of cars. The industry is expanding because of consumers' growing desire to personalise their cars with aftermarket lighting upgrades such LED upgrades and decorative lighting. The availability and affordability of technologies like adaptive headlights and laser lights in the aftermarket, together with other advancements in lighting technology, are driving demand even more. Moreover, the growing market for electric cars (EVs).
Throughout the forecast period, Asia Pacific is anticipated to be the automotive lighting market with the highest profitability. Over the past few years, Asia Pacific countries like China and India have seen notable increases in automotive manufacturing and sales, primarily in the medium-to premium luxury car segment. Asia Pacific is predicted to see an increase in the manufacturing of passenger cars, with India experiencing the strongest growth rate. Depending on the state of the national economy, the area offers a suitable selection of both high-end and cheap cars. For instance, there is a substantial demand for halogen, Xenon/HID, and LED since China and India produce more economy and mid-range automobiles. On the other hand, luxury car adoption rates are greater in South Korea and Japan, where LED lighting is the norm.
A brief shadow was thrown by COVID-19 over the worldwide automotive lighting market. Production was stopped by lockdowns and supply chain disruptions, while luxury lighting upgrades were shelved by consumers on a tight budget. Resources became scarce, and R&D stagnated. Still, the market is recovering thanks to resurgent demand and rearranged priorities. While energy-efficient LEDs are being pushed towards adoption by sustainability, safety concerns are driving interest in features like pedestrian detection and adaptive headlights. The digital push of the epidemic creates opportunities for intelligent, networked lighting systems that may interact with infrastructure and other cars. Ultimately, the industry is positioned to shine brighter, focused on safety, sustainability, and a connected future, even though the pandemic dimmed its brilliance.
A development collaboration between OSRAM Continental and REHAU aims to incorporate lighting into external components, providing automobile manufacturers with innovative lighting options that improve functionality and design flexibility. For rear combination lamps, Hella unveiled a revolutionary lighting innovation called Hella FlatLight technology. A Memorandum of Understanding (MoU) was signed by Samvardhana Motherson Automotive Systems Group BV (SMRPBV), a division of Motherson Group, and Marelli Automotive Lighting to investigate a technology collaboration focused on intelligently lighted external body components. Valeo debuted their revolutionary 360° lighting system at the Shanghai Auto Show. This technology surrounds the car with a band of light, projecting instantaneous, clear signs that other drivers can see from a distance. Pedestrians, cyclists, and scooter riders are especially susceptible to these signals
The Global Dog Cancer Therapeutics Market was estimated to be worth USD 200 million in 2022 and is anticipated to reach a value of USD 295.49 million by 2030, growing at a fast CAGR of 5% during the forecast period 2023-2030.
Advancements in veterinarian treatments and increasing incidence of cancer in dogs are the market drivers for Global Dog Cancer Therapeutics Market
Lymphoma, Mast Cell Tumours, Melanoma, Neoplasm, and Others are the segments under the Global Dog Cancer Therapeutics Market by cancer type
North American region dominates the market for Global Dog Cancer Therapeutics
Asia-Pacific is the fastest-growing region in the Global Dog Cancer Therapeutics Market
Joining thousands of companies around the world committed to making the Excellent Business Solutions.
Specify your preferred Countries, Segments, or timeframes
Unlock Country Level Outlook, Trends, Cross-country Comparability, or supply Chain Variations.
Analyst Support
Every order comes with Analyst Support.
Customization
We offer customization to cater your needs to fullest.
Verified Analysis
We value integrity, quality and authenticity the most.
